We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

400 hedge funds and large institutions have $6.44B invested in United Therapeutics in 2017 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 135 increasing their positions, 139 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 32

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

26% more capital invested

Capital invested by funds: $5.13B → $6.44B (+$1.31B)

7% more funds holding

Funds holding: 373 → 400 (+27)

0.49% more ownership

Funds ownership: 100.54% → 101.03% (+0.49%)

3% less repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 139

11% less call options, than puts

Call options by funds: $20.4M | Put options by funds: $23M

Holders
400
Holders Change
+27
Holders Change %
+7.24%
% of All Funds
9.07%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
62
Increased
135
Reduced
139
Closed
32
Calls
$20.4M
Puts
$23M
Net Calls
-$2.55M
Net Calls Change
-$45.6M

Top Buyers

1
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$47.1M
2
WCM
Wedge Capital Management
North Carolina
+$39.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$24.4M
4
Renaissance Technologies
Renaissance Technologies
New York
+$24.1M
5
Fidelity International
Fidelity International
Bermuda
+$20.8M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$43.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.4M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$31.4M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$24.2M
5
State Street
State Street
Massachusetts
-$21.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
FCBT
301
First Citizens Bank & Trust
North Carolina
$324K -$32.3K -254 -10%
GL
302
GLG LLC
New York
$305K – – –
OPPM
303
Opus Point Partners Management
New York
$303K -$262K -2,058 -50%
FC
304
Ferris Capital
Massachusetts
$296K – – –
Cerity Partners
305
Cerity Partners
New York
$294K +$508 +4 +0.2%
BRWA
306
B. Riley Wealth Advisors
Florida
$289K -$26.1K -205 -10%
RC
307
Roundview Capital
New Jersey
$274K – – –
UA
308
Unison Advisors
District of Columbia
$259K +$223K +1,753 New
AP
309
Advisor Partners
California
$256K +$2.16K +17 +0.9%
CI
310
Cigna Investments
Connecticut
$246K -$12.7K -100 -6%
VIA
311
Vident Investment Advisory
Georgia
$244K +$209K +1,647 New
PFS
312
Prospera Financial Services
Texas
$240K -$69.9K -550 -26%
VFA
313
Voya Financial Advisors
Connecticut
$239K +$204K +1,602 New
OC
314
Oppenheimer & Co
New York
$239K +$205K +1,616 New
RJFSA
315
Raymond James Financial Services Advisors
Florida
$227K +$195K +1,531 New
CIBC Asset Management
316
CIBC Asset Management
Ontario, Canada
$220K +$189K +1,490 New
HFS
317
HL Financial Services
Kentucky
$217K +$186K +1,464 New
Jane Street
318
Jane Street
New York
$216K -$135K -1,064 -42%
CIBC World Market
319
CIBC World Market
Ontario, Canada
$212K -$294K -2,313 -62%
JA
320
JOYN Advisors
Georgia
$201K +$173K +1,360 New
Daiwa Securities Group
321
Daiwa Securities Group
Japan
$200K – – –
AIM
322
Anchor Investment Management
South Carolina
$198K -$10.8K -85 -6%
LFA
323
Legacy Financial Advisors
Kentucky
$181K +$156K +1,226 New
SWM
324
SeaCrest Wealth Management
New York
$178K +$153K +1,200 New
MIFH
325
Migdal Insurance & Financial Holdings
Israel
$176K -$26.9K -212 -15%
11 12
13
14 15

UTHR Hedge Fund Activity: Q4 2017 in Review

400 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2017, worth a combined $6.44B — up 26% from $5.13B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new UTHR positions and 32 closed out — a net gain of 30 holders — while 135 added to existing stakes and 139 trimmed.

The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $47.1M. The largest seller was Morgan Stanley, cutting an estimated $43.6M.

  • 400 institutional investors held United Therapeutics (UTHR) as of Q4 2017, up from 373 in Q3 2017.
  • Funds reported $6.44B of United Therapeutics stock for Q4 2017, up 26% quarter-over-quarter.
  • 62 funds opened new United Therapeutics positions in Q4 2017 and 32 closed out, a net change of +30 holders.
  • The largest United Therapeutics buyer in Q4 2017 was Skandinaviska Enskilda Banken (SEB), an estimated $47.1M added.
  • The largest United Therapeutics seller in Q4 2017 was Morgan Stanley, an estimated $43.6M sold.

Based on aggregated 13F filings for Q4 2017.